Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein

Z Deng1, J H Morse, S L Slager

  • 1Department of Psychiatry, College of Physicians and Surgeons at Columbia University and the New York State Psychiatric Institute, New York, NY, USA.

Insights

Familial primary pulmonary hypertension (PPH) is linked to chromosome 2q33. Mutations in the BMPR2 gene, affecting bone morphogenetic protein signaling, are identified as a cause of this rare disorder.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Familial primary pulmonary hypertension (PPH) is a rare autosomal dominant disorder.
  • PPH is characterized by proliferating endothelial cells in pulmonary arterioles, leading to elevated pulmonary-artery pressures and right-ventricular failure.
  • Secondary pulmonary hypertension can be caused by factors like appetite-suppressant drugs.

Purpose of the Study:

  • To identify the genetic locus and causative gene for familial primary pulmonary hypertension.
  • To investigate the role of bone morphogenetic protein receptor type II (BMPR2) in PPH pathogenesis.

Main Methods:

  • Genotyping of 35 multiplex families using 27 microsatellite markers.
  • Haplotype analysis using the TRANSMIT program to identify shared regions.
  • Sequencing of candidate genes, including BMPR2, using denaturing high-performance liquid chromatography.

Main Results:

  • Suggestive evidence of haplotype sharing at markers GGAA19e07 and D2S307.
  • Five mutations predicting premature protein termination and two missense mutations were identified in the BMPR2 gene in affected individuals.
  • No BMPR2 mutations were found in 196 control chromosomes.

Conclusions:

  • Mutations in the BMPR2 gene are a cause of familial primary pulmonary hypertension.
  • Defects in the bone morphogenetic protein-signaling pathway are implicated in PPH.
  • The findings suggest BMPR2 may also play a role in nonfamilial forms of pulmonary hypertension.

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...